{"id":"https://openalex.org/W1969892170","doi":"https://doi.org/10.1371/journal.pone.0037243","title":"Analysis and Functional Consequences of Increased Fab-Sialylation of Intravenous Immunoglobulin (IVIG) after Lectin Fractionation","display_name":"Analysis and Functional Consequences of Increased Fab-Sialylation of Intravenous Immunoglobulin (IVIG) after Lectin Fractionation","alternate_titles":[],"publication_year":2012,"publication_date":"2012-06-04","ids":{"openalex":"https://openalex.org/W1969892170","doi":"https://doi.org/10.1371/journal.pone.0037243","mag":"1969892170","pmid":"https://pubmed.ncbi.nlm.nih.gov/22675478","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3366990"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0037243","doi":"https://doi.org/10.1371/journal.pone.0037243","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0037243","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0037243&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1969892170"],"child_works_count":10,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0037243&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085362965","display_name":"Fabian K\u00e4sermann","orcid":"https://orcid.org/0000-0002-4255-9350","observed_orcids":["https://orcid.org/0000-0002-4255-9350"]},"institutions":[{"id":"https://openalex.org/I62612085","display_name":"CSL (Switzerland)","ror":"https://ror.org/01400tq86","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210153402","https://openalex.org/I62612085"]}],"countries":["CH"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Fabian K\u00e4sermann","raw_affiliation_strings":["Research & Development, CSL Behring AG, Bern, Switzerland. fabian.kaesermann@cslbehring.com","Research & Development, CSL Behring AG, Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, CSL Behring AG, Bern, Switzerland. fabian.kaesermann@cslbehring.com","institution_ids":["https://openalex.org/I62612085"]},{"raw_affiliation_string":"Research & Development, CSL Behring AG, Bern, Switzerland","institution_ids":["https://openalex.org/I62612085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021278594","display_name":"David J. Boerema","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David J. Boerema","raw_affiliation_strings":["Research & Development, CSL Behring LLC, Kankakee, Illinois, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, CSL Behring LLC, Kankakee, Illinois, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062676514","display_name":"R\u00fcegsegger Monika","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I62612085","display_name":"CSL (Switzerland)","ror":"https://ror.org/01400tq86","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210153402","https://openalex.org/I62612085"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Monika R\u00fcegsegger","raw_affiliation_strings":["Research & Development, CSL Behring AG, Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, CSL Behring AG, Bern, Switzerland","institution_ids":["https://openalex.org/I62612085"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andreas Hofmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I62612085","display_name":"CSL (Switzerland)","ror":"https://ror.org/01400tq86","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210153402","https://openalex.org/I62612085"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andreas Hofmann","raw_affiliation_strings":["Research & Development, CSL Behring AG, Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, CSL Behring AG, Bern, Switzerland","institution_ids":["https://openalex.org/I62612085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060623336","display_name":"Sandra Wymann","orcid":"https://orcid.org/0009-0004-8266-8350","observed_orcids":["https://orcid.org/0009-0004-8266-8350"]},"institutions":[{"id":"https://openalex.org/I62612085","display_name":"CSL (Switzerland)","ror":"https://ror.org/01400tq86","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210153402","https://openalex.org/I62612085"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sandra Wymann","raw_affiliation_strings":["Research & Development, CSL Behring AG, Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, CSL Behring AG, Bern, Switzerland","institution_ids":["https://openalex.org/I62612085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064956979","display_name":"Adrian W. Zuercher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I62612085","display_name":"CSL (Switzerland)","ror":"https://ror.org/01400tq86","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210153402","https://openalex.org/I62612085"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Adrian W. Zuercher","raw_affiliation_strings":["Research & Development, CSL Behring AG, Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, CSL Behring AG, Bern, Switzerland","institution_ids":["https://openalex.org/I62612085"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069802631","display_name":"Sylvia Miescher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I62612085","display_name":"CSL (Switzerland)","ror":"https://ror.org/01400tq86","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210153402","https://openalex.org/I62612085"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sylvia Miescher","raw_affiliation_strings":["Research & Development, CSL Behring AG, Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, CSL Behring AG, Bern, Switzerland","institution_ids":["https://openalex.org/I62612085"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5085362965"],"corresponding_institution_ids":["https://openalex.org/I62612085"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":5.1518,"has_fulltext":true,"cited_by_count":135,"citation_normalized_percentile":{"value":0.97145033,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"7","issue":"6","first_page":"e37243","last_page":"e37243"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","score":0.5238999724388123,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","score":0.5238999724388123,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.4652999937534332,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/sialic-acid","display_name":"sialic acid","score":0.7839999794960022},{"id":"https://openalex.org/keywords/sambucus-nigra-agglutinin","display_name":"Sambucus nigra agglutinin","score":0.9359999895095825},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.9070000052452087},{"id":"https://openalex.org/keywords/fab-region","display_name":"Fab region","score":0.42899999022483826},{"id":"https://openalex.org/keywords/igg-subclasses","display_name":"IgG subclasses","score":0.5339999794960022},{"id":"https://openalex.org/keywords/monocytes","display_name":"monocytes","score":0.8820000290870667},{"id":"https://openalex.org/keywords/mcp-1","display_name":"MCP-1","score":0.8379999995231628},{"id":"https://openalex.org/keywords/autoantibodies","display_name":"autoantibodies","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C2780115458","wikidata":"https://www.wikidata.org/wiki/Q419311","display_name":"Sialic acid","level":2,"score":0.8849138021469116},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7235878705978394},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6753603219985962},{"id":"https://openalex.org/C2780758401","wikidata":"https://www.wikidata.org/wiki/Q408693","display_name":"Lectin","level":2,"score":0.6735882759094238},{"id":"https://openalex.org/C2778671442","wikidata":"https://www.wikidata.org/wiki/Q310828","display_name":"N-Acetylneuraminic acid","level":3,"score":0.5538705587387085},{"id":"https://openalex.org/C206212055","wikidata":"https://www.wikidata.org/wiki/Q2553138","display_name":"Glycan","level":3,"score":0.534814178943634},{"id":"https://openalex.org/C2780898057","wikidata":"https://www.wikidata.org/wiki/Q79448","display_name":"Immunoglobulin G","level":3,"score":0.5234795808792114},{"id":"https://openalex.org/C207545495","wikidata":"https://www.wikidata.org/wiki/Q2573513","display_name":"Agglutinin","level":3,"score":0.49078235030174255},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.49060240387916565},{"id":"https://openalex.org/C97428945","wikidata":"https://www.wikidata.org/wiki/Q15305109","display_name":"Fractionation","level":2,"score":0.4642658233642578},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4247405230998993},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.282986581325531},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.2247961461544037},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19536030292510986},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.1413814127445221}],"mesh":[{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000918","descriptor_name":"Antibody Specificity","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D002846","descriptor_name":"Chromatography, Affinity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004591","descriptor_name":"Electrophoresis, Polyacrylamide Gel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004912","descriptor_name":"Erythrocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004912","descriptor_name":"Erythrocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005591","descriptor_name":"Chemical Fractionation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007140","descriptor_name":"Immunoglobulin Fab Fragments","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019158","descriptor_name":"N-Acetylneuraminic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D037121","descriptor_name":"Plant Lectins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D054788","descriptor_name":"Ribosome Inactivating Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":7,"locations":[{"id":"doi:10.1371/journal.pone.0037243","doi":"https://doi.org/10.1371/journal.pone.0037243","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0037243","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0037243&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2375794","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3366990","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3366990","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3366990/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:22675478","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22675478","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:7d8f17cd3e8b4fdaa764d0a96d1bda80","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/7d8f17cd3e8b4fdaa764d0a96d1bda80","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 7, Iss 6, p e37243 (2012)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/124322","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/Analysis_and_Functional_Consequences_of_Increased_Fab_Sialylation_of_Intravenous_Immunoglobulin_IVIG_after_Lectin_Fractionation/124322","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.665.1571","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.665.1571","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366990/pdf/pone.0037243.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0037243","doi":"https://doi.org/10.1371/journal.pone.0037243","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0037243","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0037243&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1969892170.pdf","grobid_xml":"https://content.openalex.org/works/W1969892170.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W187857992","https://openalex.org/W1481575941","https://openalex.org/W1507663083","https://openalex.org/W1583531858","https://openalex.org/W1826144049","https://openalex.org/W1964112957","https://openalex.org/W1966455480","https://openalex.org/W1977978637","https://openalex.org/W1979820418","https://openalex.org/W1985075809","https://openalex.org/W1985240611","https://openalex.org/W1989449493","https://openalex.org/W1994825342","https://openalex.org/W1997337646","https://openalex.org/W2006521244","https://openalex.org/W2008578152","https://openalex.org/W2017239895","https://openalex.org/W2024505041","https://openalex.org/W2030130606","https://openalex.org/W2031882870","https://openalex.org/W2032983601","https://openalex.org/W2035433348","https://openalex.org/W2036506588","https://openalex.org/W2048326114","https://openalex.org/W2049310835","https://openalex.org/W2051293199","https://openalex.org/W2051666192","https://openalex.org/W2071682030","https://openalex.org/W2076119890","https://openalex.org/W2082632419","https://openalex.org/W2084469556","https://openalex.org/W2115471441","https://openalex.org/W2136732030","https://openalex.org/W2138576617","https://openalex.org/W2142995477","https://openalex.org/W2144721017","https://openalex.org/W2153346995","https://openalex.org/W2616639792","https://openalex.org/W4211259892","https://openalex.org/W6808177161"],"related_works":["https://openalex.org/W2017239895","https://openalex.org/W1538969863","https://openalex.org/W2027577085","https://openalex.org/W2153346995","https://openalex.org/W1559576006","https://openalex.org/W2902019191","https://openalex.org/W2006521244","https://openalex.org/W4415970747"],"abstract_inverted_index":{"It":[0],"has":[1],"been":[2],"proposed":[3],"that":[4,203],"the":[5,16,104,108,119,130,138,160,165,219,226],"anti-inflammatory":[6,72,172,231],"effects":[7,194],"of":[8,19,68,95,111,137,146,150,159,189,206,214],"intravenous":[9],"immunoglobulin":[10],"(IVIG)":[11],"might":[12],"be":[13],"due":[14],"to":[15,142,175],"small":[17],"fraction":[18,167,211],"Fc-sialylated":[20],"IgG.":[21],"In":[22],"this":[23],"study":[24],"we":[25],"biochemically":[26],"and":[27,61,71,89,100,152,186],"functionally":[28],"characterized":[29],"sialic":[30,63,112,140,220],"acid-enriched":[31],"IgG":[32,43,97],"obtained":[33],"by":[34,46,180],"Sambucus":[35],"nigra":[36],"agglutinin":[37],"(SNA)":[38],"lectin":[39],"fractionation.":[40],"Two":[41],"main":[42],"fractions":[44],"isolated":[45],"elution":[47],"with":[48,235],"lactose":[49,53],"(E1)":[50],"or":[51,84,177],"acidified":[52],"(E2)":[54],"were":[55,195],"analyzed":[56],"for":[57],"total":[58],"IgG,":[59,217],"F(ab')(2)":[60],"Fc-specific":[62],"acid":[64,113,141,221],"content,":[65],"their":[66],"pattern":[67,158],"specific":[69],"antibodies":[70],"potential":[73],"in":[74,77,98,103,118,129,225],"a":[75,124,147,155,169,209],"human":[76],"vitro":[78],"inflammation":[79],"system":[80],"based":[81],"on":[82,184],"LPS-":[83],"PHA-stimulated":[85],"whole":[86],"blood.":[87],"HPLC":[88],"LC-MS":[90],"testing":[91],"revealed":[92],"an":[93],"increase":[94,126],"sialylated":[96,161,216],"E1":[99,176],"more":[101,170],"substantially":[102],"E2":[105,166],"fraction.":[106],"Significantly,":[107],"increased":[109],"amount":[110],"residues":[114],"was":[115,127,233],"primarily":[116],"found":[117,224],"Fab":[120,139,227,236],"region":[121],"whereas":[122],"only":[123],"minor":[125,210],"observed":[128],"Fc":[131,238],"region.":[132,228],"This":[133],"indicates":[134],"preferential":[135],"binding":[136],"SNA.":[143],"ELISA":[144],"analyses":[145],"representative":[148],"range":[149],"pathogen":[151],"auto-antigens":[153],"indicated":[154],"skewed":[156],"antibody":[157],"IVIG":[162,207],"fractions.":[163],"Finally,":[164],"exerted":[168],"profound":[171],"effect":[173],"compared":[174],"IVIG,":[178],"evidenced":[179],"reduced":[181,187],"CD54":[182],"expression":[183],"monocytes":[185],"secretion":[188],"MCP-1":[190],"(CCL2);":[191],"again":[192],"these":[193],"Fab-":[196],"but":[197],"not":[198,237],"Fc-dependent.":[199],"Our":[200],"results":[201],"show":[202],"SNA":[204],"fractionation":[205],"yields":[208],"(approx.":[212],"10%)":[213],"highly":[215],"wherein":[218],"is":[222],"mainly":[223],"The":[229],"tested":[230],"activity":[232],"associated":[234],"sialylation.":[239]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1969892170","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":24},{"year":2013,"cited_by_count":17},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
